» Articles » PMID: 23691305

Psychiatric Morbidity and Other Factors Affecting Treatment Adherence in Pulmonary Tuberculosis Patients

Overview
Publisher Wiley
Date 2013 May 22
PMID 23691305
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

As the overall prevalence of TB remains high among certain population groups, there is growing awareness of psychiatric comorbidity, especially depression and its role in the outcome of the disease. The paper attempts a holistic approach to the effects of psychiatric comorbidity to the natural history of tuberculosis. In order to investigate factors associated with medication nonadherence among patients suffering from tuberculosis, with emphasis on psychopathology as a major barrier to treatment adherence, we performed a systematic review of the literature on epidemiological data and past medical reviews from an historical perspective, followed by theoretical considerations upon the relationship between psychiatric disorders and tuberculosis. Studies reporting high prevalence rates of psychiatric comorbidity, especially depression, as well as specific psychological reactions and disease perceptions and reviews indicating psychiatric complications as adverse effects of anti-TB medication were included. In sum, data concerning factors affecting medication nonadherence among TB patients suggested that better management of comorbid conditions, especially depression, could improve the adherence rates, serving as a framework for the effective control of tuberculosis, but further studies are necessary to identify the optimal way to address such issues among these patients.

Citing Articles

The risk of developing depression in tuberculosis survivors: a nationwide cohort study in South Korea.

Kim H, Jung J, Han K, Kim H, Jeon H Front Psychiatry. 2025; 16:1425637.

PMID: 40060746 PMC: 11885284. DOI: 10.3389/fpsyt.2025.1425637.


Determinants of unfavourable treatment outcomes of drug-resistant tuberculosis cases in Malaysia: a case-control study.

Kamarul Zaman M, Nik Husain N, Sidek M, Abu Bakar Z BMJ Open. 2025; 15(2):e093391.

PMID: 39965941 PMC: 11836788. DOI: 10.1136/bmjopen-2024-093391.


Pulmonary Tuberculosis-Associated Morbidity in Africa: A Systematic Review.

Okeke C, Ibe C, Nduji O, Ndulue C, Ngige O, Amuchie C Cureus. 2025; 17(1):e77569.

PMID: 39958055 PMC: 11830121. DOI: 10.7759/cureus.77569.


Symptom network analysis of insomnia-depression-anxiety-stigma in tuberculosis patients.

Liu X, Qiu X, Lan H, Diao L, Huang W, Wen Y Front Psychiatry. 2025; 15:1513524.

PMID: 39917380 PMC: 11798919. DOI: 10.3389/fpsyt.2024.1513524.


Prevalence and Predictors of Depression Among Drug-Sensitive Tuberculosis Patients - A Cross-Sectional Study.

Sharma D, Goel N, Sidana A, Sandha K, Bishnoi M Indian J Community Med. 2024; 49(6):879-882.

PMID: 39668921 PMC: 11633267. DOI: 10.4103/ijcm.ijcm_167_23.


References
1.
Dye C, Scheele S, Dolin P, Pathania V, Raviglione M . Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999; 282(7):677-86. DOI: 10.1001/jama.282.7.677. View

2.
Gibson N, Cave A, Doering D, Ortiz L, Harms P . Socio-cultural factors influencing prevention and treatment of tuberculosis in immigrant and Aboriginal communities in Canada. Soc Sci Med. 2005; 61(5):931-42. DOI: 10.1016/j.socscimed.2004.10.026. View

3.
Sachdeva J, Shergill C, Sidhu B . Prevalence of psychiatric morbidity among medical in-patients. Indian J Psychiatry. 2011; 28(4):293-6. PMC: 3172516. View

4.
WIEDORN W, Ervin F . Schizophreniclike psychotic reactions with administration of isoniazid. AMA Arch Neurol Psychiatry. 1954; 72(3):321-4. DOI: 10.1001/archneurpsyc.1954.02330030055005. View

5.
Zellweger J, Sauty A, Uldry C, Iorillo D, Burnier M . Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis. 1998; 2(7):525-30. View